NASDAQ:CYRX - CryoPort Stock Price, Forecast & News

CryoPort trades on the NASDAQ under the ticker symbol "CYRX."

CryoPort Inc (NASDAQ:CYRX) released its quarterly earnings data on Thursday, November, 7th. The consumer goods maker reported ($0.05) EPS for the quarter, topping the Thomson Reuters' consensus estimate of ($0.07) by $0.02. The consumer goods maker had revenue of $9.58 million for the quarter, compared to analyst estimates of $9.49 million. CryoPort had a negative return on equity of 26.50% and a negative net margin of 64.63%. The business's quarterly revenue was up 81.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.07) EPS. View CryoPort's Earnings History.

CryoPort is scheduled to release their next quarterly earnings announcement on Thursday, March 5th 2020. View Earnings Estimates for CryoPort.

4 analysts have issued 12 month price targets for CryoPort's shares. Their forecasts range from $22.00 to $26.00. On average, they anticipate CryoPort's stock price to reach $24.00 in the next year. This suggests a possible upside of 64.2% from the stock's current price. View Analyst Price Targets for CryoPort.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CryoPort in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CryoPort.

News headlines about CYRX stock have been trending somewhat negative on Monday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CryoPort earned a news impact score of -1.0 on InfoTrie's scale. They also assigned news headlines about the consumer goods maker a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the next few days. View News Stories for CryoPort.

CryoPort saw a decrease in short interest during the month of October. As of October 15th, there was short interest totalling 6,220,000 shares, a decrease of 13.6% from the September 15th total of 7,200,000 shares. Based on an average daily volume of 660,200 shares, the days-to-cover ratio is presently 9.4 days. Currently, 17.7% of the company's stock are sold short. View CryoPort's Current Options Chain.

Some companies that are related to CryoPort include Forward Air (FWRD), Hub Group (HUBG), Echo Global Logistics (ECHO), Roadrunner Transportation Systems (RRTS) and Sino-Global Shipping America (SINO).

Based on aggregate information from My MarketBeat watchlists, some companies that other CryoPort investors own include Gilead Sciences (GILD), ACADIA Pharmaceuticals (ACAD), Exelixis (EXEL), bluebird bio (BLUE), Global Blood Therapeutics (GBT), Micron Technology (MU), Amgen (AMGN), Huron Consulting Group (HURN), Neurocrine Biosciences (NBIX) and Vertex Pharmaceuticals (VRTX).

CryoPort's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Chevy Chase Trust Holdings Inc. (4.61%), TimesSquare Capital Management LLC (3.78%), State Street Corp (2.61%), Columbus Circle Investors (0.99%), Creative Planning (0.97%) and Granahan Investment Management Inc. MA (0.93%). Company insiders that own CryoPort stock include Jerrell Shelton, Richard J Berman and Robert Stefanovich. View Institutional Ownership Trends for CryoPort.

CYRX stock was sold by a variety of institutional investors in the last quarter, including Creative Planning, Millennium Management LLC, Perkins Capital Management Inc., Taylor Frigon Capital Management LLC, Essex Investment Management Co. LLC, D.A. Davidson & CO., Rice Hall James & Associates LLC and Taylor Wealth Management Partners. Company insiders that have sold CryoPort company stock in the last year include Richard J Berman and Robert Stefanovich. View Insider Buying and Selling for CryoPort.

CYRX stock was purchased by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Chevy Chase Trust Holdings Inc., Columbus Circle Investors, State Street Corp, SG Capital Management LLC, Granahan Investment Management Inc. MA, Castleark Management LLC and SG Americas Securities LLC. View Insider Buying and Selling for CryoPort.

Shares of CYRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CYRX stock can currently be purchased for approximately $14.62.

CryoPort has a market capitalization of $523.98 million and generates $19.63 million in revenue each year. The consumer goods maker earns $-9,560,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. View Additional Information About CryoPort.

The official website for CryoPort is http://www.cryoport.com/.

CryoPort's mailing address is 17305 DAIMLER STREET, IRVINE CA, 92614. The consumer goods maker can be reached via phone at 949-470-2300 or via email at [email protected]